ADVM
AdverumยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ADVM Profile
Adverum Biotechnologies, Inc.
A clinical-stage company that develops therapeutics based on novel gene therapies to treat ocular and rare diseases
100 Cardinal Way, Redwood City, California 94063
--
Adverum Biotechnologies, Inc., was founded in Delaware on July 17, 2006. The company is a clinical-stage gene therapy company targeting unmet medical needs for serious rare and eye diseases. Using their next-generation adeno-associated virus (" AAV ") -based directed evolution platform, they generate candidates for gene therapy products designed to provide durable efficacy by inducing sustained expression of therapeutic proteins. Their core competencies include clinical development and in-house manufacturing expertise, particularly in process development, test development and current Good Manufacturing Practices (" cGMP ") quality control.
